ATTD: Advanced Technologies and Treatments for Diabetes
ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research…
- Indexed episodes, last 90 days
- 8
- Latest publication
- Sep 22, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 14, 2026
Latest episodes
The Science Behind Weekly Insulin (opens the original)
Read excerpt
In this episode, we explore the science behind weekly insulin, including the pharmacology of weekly insulin, its mechanism of action, how it differs from daily insulin formulations, and why it provides consistent control over a longer period. Guest: Dr. Manasi Shah, Assistant Professor of Medicine at Eastern Virginia Medical School and Director of the Inpatient Diabetes Program at Sentara Norfolk General Hospital Key discussion points: What are the key pharmacokinetic properties that enable once
The Weekly Insulin Breakthrough (opens the original)
Read excerpt
In this inaugural episode of ATTD Diabetes Talks: The Power of Weekly Insulin , we delve into the evolution and future of basal insulin therapy. Host Diana Isaacs sits down with Dr. Rodolfo Galindo to explore the pharmacological innovations behind weekly insulin formulations and discuss how this breakthrough is reshaping modern diabetes management. Guest: Dr. Rodolfo Galindo (Associate Professor of Medicine and Director of the Comprehensive Diabetes Center at the University of Miami Health Syste
Unmet needs in paediatric diabetes – the potential role of inhaled insulin (opens the original)
Read excerpt
Join host Dr. David Ahn and guest Dr. Michael Haller (Professor and Chief of Pediatric Endocrinology at the University of Florida and Chair of TrialNet) as they take a comprehensive review of the evidence base and remaining gaps for inhaled insulin use in pediatric and adolescent populations In this final episode, we dive into: Key Challenges in Pediatrics: Unmet needs in pediatric insulin therapy, including injection fatigue and tech-retention issues for active youth. The INHALE-1 Study: A deep
Use of inhaled insulin with automated insulin delivery (AID) systems (opens the original)
Read excerpt
Join host Dr. David Ahn and guest Dr. Roy Beck (Founder and Medical Director of the Jaeb Center for Health Research) as they explore the integration of inhaled insulin with automated insulin delivery (AID) systems. In this episode, we dive into: The potential of combining inhaled insulin with current AID technologies. Theoretical advantages, including postprandial management. Current evidence, clinical considerations, and existing evidence gaps. Practical insights for clinicians on patient educa
Overcoming therapeutic inertia with inhaled insulin (opens the original)
Read excerpt
In this episode, we examine the concept of "therapeutic inertia" in diabetes care. Dr. David Ahn is joined by Dr. Grazia Aleppo, Professor of Medicine at the Feinberg School of Medicine, Northwestern University, to explore how inhaled insulin can help address the clinical and behavioral barriers often associated with insulin initiation. Key discussion points: Defining therapeutic inertia in the context of insulin initiation. Common clinician and patient-related barriers that contribute to treatm
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.
See coverage about ATTD: Advanced Technologies and Treatments for Diabetes